Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.73 million shares were traded. BDTX stock price reached its highest trading level at $3.28 during the session, while it also had its lowest trading level at $3.09.
Ratios:
We take a closer look at BDTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.24 and its Current Ratio is at 9.24. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.
On July 31, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Versant Venture Capital VI, L. sold 221,600 shares of BDTX for $1,400,556 on Aug 28 ’24. The 10% Owner now owns 3,726,341 shares after completing the transaction at $6.32 per share. On Jul 31 ’24, another insider, David Epstein, who serves as the Former Employer of the company, bought 50,000 shares for $6.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 181391696 and an Enterprise Value of 50578804. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 51.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.59 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 0.723 whereas that against EBITDA is -70.641.
Stock Price History:
The Beta on a monthly basis for BDTX is 2.88, which has changed by -0.48796147 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $6.75, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is 30.13%, while the 200-Day Moving Average is calculated to be 36.84%.
Shares Statistics:
According to the various share statistics, BDTX traded on average about 1.17M shares per day over the past 3-months and 1062770 shares per day over the past 10 days. A total of 56.68M shares are outstanding, with a floating share count of 43.28M. Insiders hold about 23.88% of the company’s shares, while institutions hold 62.40% stake in the company. Shares short for BDTX as of 1751241600 were 5805076 with a Short Ratio of 4.98, compared to 1748563200 on 7570062. Therefore, it implies a Short% of Shares Outstanding of 5805076 and a Short% of Float of 14.67.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Black Diamond Therapeutics Inc (BDTX) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.21 and low estimates of -$0.24.
Analysts are recommending an EPS of between $0.38 and $0.24 for the fiscal current year, implying an average EPS of $0.31. EPS for the following year is -$0.75, with 2.0 analysts recommending between -$0.71 and -$0.8.
